Proteostasis Therapeutics
closedInnovative CFTR modulators for cystic fibrosis treatment through advanced ex vivo screening and clinical trials. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€135—202m (Dealroom.co estimates Sep 2015.)
Share price
$22.2 PTI
Cambridge Massachusetts (HQ)
Authorizing premium user...